Glucocorticoid treatment

DRUG2 trials

Sponsors

Prof Dr Frank Buttgereit, Bristol-Myers Squibb

Conditions

Giant Cell ArteritisInflammatory RheumatismOsteoporosis

Phase 3

A Study to Evaluate Efficacy and Safety of Subcutaneous Abatacept With Steroid Treatment Compared to Steroid Treatment Alone in Adults With Giant Cell Arteritis (GCA)

WithdrawnNCT03192969

Bristol-Myers SquibbGiant Cell Arteritis

Start: 2017-07-15End: 2021-11-23Updated: 2017-07-12

Unknown Phase

Glucocorticoid-induced Osteoporosis in Patients With Chronic Inflammatory Rheumatic Diseases or Psoriasis

RecruitingNCT02719314

Prof Dr Frank ButtgereitInflammatory Rheumatism, Osteoporosis

Start: 2015-12-31End: 2029-07-31Target: 10000Updated: 2025-02-13

Related Papers

Optimising both disease control and glucocorticoid dosing is essential for bone protection in patients with rheumatic disease.

2022-08-1138 citations